Crispr Therapeutics shares owned by Horizon Kinetics Asset Management
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Horizon Kinetics Asset Management
from 13F filings
Historical chart of Horizon Kinetics Asset Management investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by Horizon Kinetics Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Crispr Therapeutics by Horizon Kinetics Asset Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $669k | 11k | 62.60 |
| 2023-09-30 | $505k | 11k | 45.39 |
| 2023-06-30 | $625k | 11k | 56.14 |
| 2023-03-31 | $503k | 11k | 45.23 |
| 2022-12-31 | $249k | 6.1k | 40.65 |
| 2022-09-30 | $400k | 6.1k | 65.31 |
| 2022-06-30 | $372k | 6.1k | 60.73 |
| 2022-03-31 | $384k | 6.1k | 62.69 |
| 2021-12-31 | $464k | 6.1k | 75.76 |
| 2021-09-30 | $686k | 6.1k | 112.00 |
| 2021-06-30 | $992k | 6.1k | 161.96 |
| 2021-03-31 | $746k | 6.1k | 121.80 |
| 2020-12-31 | $938k | 6.1k | 153.14 |
| 2020-09-30 | $512k | 6.1k | 83.59 |
| 2020-06-30 | $450k | 6.1k | 73.47 |
| 2020-03-31 | $217k | 5.1k | 42.34 |
More positions owned by Horizon Kinetics Asset Management
View all positions for Horizon Kinetics Asset Management